TGF-β-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway

European Journal of Immunology

Volumn 35, Issue 3, 2005, Pages 727-737

  Lalive, Patrice H ^a   Paglinawan, Rey ^a   Biollaz, Gregoire ^a   Kappos, Elisabeth A ^a   Leone, Dino P ^b   Malipiero, Ursula ^a   Relvas, Joao B ^b   Moransard, Martijn ^a   Suter, Tobias ^a   Fontana, Adriano ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Autoimmunity; Chemokines; Cytokines; EAE MS; Th1 Th2 cells

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MICROGLIA; MOUSE; MOUSE STRAIN; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NERVE CELL STIMULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REMYELINIZATION; SPLEEN CELL; STEM CELL;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CHEMOTAXIS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION; HEPATOCYTE GROWTH FACTOR; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MICROGLIA; MICROSCOPY, CONFOCAL; OLIGODENDROGLIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-MET; REMISSION, SPONTANEOUS; SPINAL CORD DISEASES; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 20144365008     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425430     Document Type: Article

References (40)

1. Compston, A. and Coles, A., Multiple sclerosis. Lancet 2002. 359: 1221-1231.
2. Steinman, L., Martin, R., Bernard, C., Conlon, P. and Oksenberg, J. R., Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci 2002. 25: 491-505.
3. Steinman, L., Multiple sclerosis: a two-stage disease. Nat. Immunol. 2001. 2: 762-764.
4. Miller, S. D. and Shevach, E. M., Immunoregulation of experimental autoimmune encephalomyelitis: editorial overview. Res. Immunol. 1998. 149: 753-759.
5. Glabinski, A. R., Bielecki, B. and Ransohoff, R. M., Chemokine up-regulation follows cytokine expression in chronic relapsing experimental autoimmune encephalomyelitis. Scand. J. Immunol. 2003. 58: 81-88.
6. Ransohoff, R. M., The chemokine system in neuroinflammation: an update. J. Infect. Dis. 2002. 186 Suppl 2: S152-156.
7. Eugster, H. P., Frei, K., Bachmann, R., Bluethmann, H., Lassmann, H. and Fontana, A., Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur. J. Immunol. 1999. 29: 626-632.
8. Probert, L., Akassoglou, K., Pasparakis, M., Kontogeorgos, G. and Kollias, G., Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA 1995. 92: 11294-11298.
9. Selmaj, K. W. and Raine, C. S., Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 1988. 23: 339-346.
10. Zajicek, J. P., Wing, M., Scolding, N. J. and Compston, D. A., Interactions between oligodendrocytes and microglia. A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing. Brain 1992. 115 (Pt 6): 1611-1631.
11. Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J. and Lane, T. E., Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 1993. 151: 2132-2141.
12. Louis, J. C., Magal, E., Takayama, S. and Varon, S., CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 1993. 259: 689-692.
13. Weiner, H. L., Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol. Rev. 2001. 182: 207-214.
14. Gorelik L. and Flavell, R. A., Transforming growth factor-beta in T-cell biology. Nat. Rev. Immunol. 2002. 2: 46-53.
15. Franklin, R. J., Why does remyelination fail in multiple sclerosis? Nat. Rev. Neurosci. 2002. 3: 705-714.
16. Paglinawan, R., Malipiero, U., Schlapbach, R., Frei, K., Reith, W. and Fontana, A., TGFbeta directs gene expression of activated microglia to an anti-inflammatory phenotype strongly focusing on chemokine genes and cell migratory genes. Glia 2003. 44: 219-231.
17. Gerard, C. and Rollins, B. J., Chemokines and disease. Nat. Immunol. 2001. 2: 108-115.
18. Yan, H. and Rivkees, S. A., Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. J. Neurosci. Res. 2002. 69: 597-606.
19. Ebens, A., Brose, K., Leonardo, E. D., Hanson, M. G., Jr., Bladt, F., Birchmeier, C., Barres, B. A. and Tessier-Lavigne, M., Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 1996. 17: 1157-1172.
20. LeBaron, R. G., Bezverkov, K. I., Zimber, M. P., Pavelec, R., Skonier, J. and Purchio, A. F., Beta IG-H3, a novel secretory protein inducible by transforming growth factor-beta, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro. J. Invest. Dermatol. 1995. 104: 844-849.
21. Kothapalli, D., Frazier, K. S., Welply, A., Segarini, P. R. and Grotendorst, G. R., Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ. 1997. 8: 61-68.
22. Takekawa, M., Tatebayashi, K., Itoh, F., Adachi, M., Imai, K. and Saito, H., Smad-dependent GADD45beta expression mediates delayed activation of p38 MAP kinase by TGF-beta. EMBO J. 2002. 21: 6473-6482.
23. Su, S., DiBattista, J. A., Sun, Y., Li, W. Q. and Zafarullah, M., Up-regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-beta in articular chondrocytes is mediated by serine/threonine and tyrosine kinases. J. Cell Biochem. 1998. 70: 517-527.
24. Sawdey, M., Podor, T. J. and Loskutoff, D. J., Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha. J. Biol. Chem. 1989. 264: 10396-10401.
25. Maina, F. and Klein, R., Hepatocyte growth factor, a versatile signal for developing neurons. Nat. Neurosci. 1999. 2: 213-217.
26. Zhang, L., Himi, T. and Murota, S., Induction of hepatocyte growth factor (HGF) in rat microglial cells by prostaglandin E(2). J. Neurosci. Res. 2000. 62: 389-395.
27. Tsai, H. H., Frost, E., To, V., Robinson, S., Ffrench-Constant, C., Geertman, R., Ransohoff, R. M. and Miller, R. H., The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell 2002. 110: 373-383.
28. Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J. et al., Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002. 8: 500-508.
29. McKinnon, R. D., Piras, G., Ida, J. A., Jr. and Dubois-Dalcq, M., A role for TGF-beta in oligodendrocyte differentiation. J. Cell Biol. 1993. 121: 1397-1407.
30. Yo, Y., Morishita, R., Yamamoto, K., Tomita, N., Kida, I., Hayashi, S., Moriguchi, A., Kato, S., Matsumoto, K., Nakamura, T., Higaki, J. and Ogihara, T., Actions of hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease. Kidney Int. 1998. 53: 50-58.
31. Gohda, E., Matsunaga, T., Kataoka, H., Takebe, T. and Yamamoto, I., Induction of hepatocyte growth factor in human skin fibroblasts by epidermal growth factor, platelet-derived growth factor and fibroblast growth factor. Cytokine 1994. 6: 633-640.
32. Lewis, M. P., Lygoe, K. A., Nystrom, M. L., Anderson, W. P., Speight, P. M., Marshall, J. F. and Thomas, G. J., Tamour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br. J. Cancer 2004. 90: 822-832.
33. Wang, S., Denichilo, M., Brubaker, C. and Hirschberg, R., Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int. 2001. 60: 96-105.
34. Leask A., Holmes, A., Black, C. M. and Abraham, D. J., Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J. Biol. Chem 2003. 278: 13008-13015.
35. King, C., Davies, J., Mueller, R., Lee, M. S., Krahl, T., Yeung, B., O'Connor, E. and Sarvetnick, N., TGF-beta1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity 1998. 8: 601-613.
36. Issazadeh, S., Navikas, V., Schaub, M., Sayegh, M. and Khoury, S., Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J. Immunol. 1998. 161: 1104-1112.
37. Wolswijk, G., Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 2002. 125: 338-349.
38. John, G. R., Shankar, S. L., Shafit-Zagardo, B., Massimi, A., Lee, S. C., Raine, C. S. and Brosnan, C. F., Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. Med. 2002. 8: 1115-1121.
39. Frost, E. E., Milner, R. and Ffrench-Constant, C., Migration assays for oligodendrocyte precursor cells. Methods Mol. Biol. 2000. 139: 265-278.
40. Milner, R. and Ffrench-Constant C., A developmental analysis of oligodendroglial integrins in primary cells: changes in alpha v-associated beta subunits during differentiation. Development 1994. 120: 3497-3506.